Emergent BioSolutions, Inc. (EBS)
7.995
-0.08
(-1.05%)
USD |
NYSE |
Mar 18, 15:59
8.01
+0.02
(+0.19%)
After-Hours: 19:55
Emergent BioSolutions Total Assets (Quarterly) : 1.332B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 43.67B |
| Eli Lilly & Co. | 112.48B |
| Penumbra, Inc. | 1.827B |
| Disc Medicine, Inc. | 806.88M |
| MetaVia, Inc. | 14.76M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 809.40M |
| Shareholders Equity (Quarterly) | 522.60M |
| Debt to Equity Ratio | 1.117 |
| Current Ratio | 5.011 |
| Net Debt Paydown Yield | 2.87% |